Acelrx Pharmaceuticals reported $9.44M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 9.44M 1.26M
Baxter International BAX:US $ 3395M 149M
Becton, Dickinson and BDX:US $ 4104M 255M
Cara Therapeutics CARA:US $ 32.7M 1.64M
Heron Therapeutics HRTX:US $ 86.38M 12.19M
Intra Cellular Therapies ITCI:US $ 107.66M 4.02M
Johnson & Johnson JNJ:US $ 18.18B 616M
Pain Therapeutics PTIE:US $ 17.82M 3.38M
Pfizer PFE:US $ 15640M 148M
Smiths SMIN:LN 1.04B 38M
Teva Pharmaceutical TEVA:IT 4.74B 361M
Xeris Pharmaceuticals Inc XERS:US $ 51.15M 18.55M